Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Repligen Corp RGEN

Healthcare Biotechnology
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre... see more

Current News (NDAQ:RGEN)

Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair

GlobeNewswire 13 days ago

Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference

GlobeNewswire December 18, 2025

Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows

GlobeNewswire December 16, 2025

Repligen Corporation to Present at Evercore Healthcare Conference

GlobeNewswire November 26, 2025

Repligen Corporation to Present at Upcoming November Conferences

GlobeNewswire November 4, 2025

Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance

GlobeNewswire October 28, 2025

Repligen to Report Third Quarter 2025 Financial Results

GlobeNewswire October 15, 2025

Repligen Corporation to Present at Upcoming September Conferences

GlobeNewswire August 22, 2025

Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization

GlobeNewswire July 31, 2025
View More News ››

Opinion & Analysis (NDAQ:RGEN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:RGEN)

Repligen Corporation (NASDAQ:RGEN): Delivering Innovative Bi

http://beyondspx.com/2024/08/02/repligen-corporation-nasdaqrgen-delivering-innovative-biopr
MikeTester - August 3, 2024

Healthcare Stocks to Watch

There is a wide array of offerings from innovative care to advanced digital technologies from every corner of the market assessing just...
SHFeatureArticl - February 28, 2020

settled a patent suit

settled a patent suit that it filed with the University of Michigan against Bristol-Myers Squibb . The deal entitles Repligen to an...
mart33 - April 10, 2008

Good Ole Boy''s

CoastalTrader - May 30, 2007

MARCH WATCH 2007

ABN BAY CVV ETG ESO GZZ HAT IRK LGR NCR PEM PDP PRD PGD ROK...
CoastalTrader - March 10, 2007

Jan 2007 II

CoastalTrader - January 16, 2007
View more Bullboard ››

Lipari Mining Ltd.

Lipari Mining Ltd.

Lipari Mining is a natural diamond producer from its 100% owned Braúna diamond mine in Brazil. The Braúna mine is the only ...
View More »

Podcasts